Arielle Genevois-Borella

USPTO Granted Patents = 25 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Thias, FR (2007)
Paris, FR (2013)
Thiais, FR (1997 - 2014)

Company Filing History:

9 out of 247

Rhone-poulenc Rorer S.a.

Sanofi-a Ventis Deutschland Gmbh

Years Active: 1997-2014

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8633222 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2014-01-21),

2. 8372864 - 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof (2013-02-12),

3. 8067443 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2011-11-29),

4. 8063068 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2011-11-22),

5. 8048893 - Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them (2011-11-01),

6. 8030320 - Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides and of 4-OXO-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics (2011-10-04),

7. 7884123 - Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof (2011-02-08),

8. 7714001 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2010-05-11),

9. 7638521 - 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them (2009-12-29),

10. 7531663 - 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them (2009-05-12),

11. 7524838 - Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them (2009-04-28),

12. 7517881 - Triazine derivatives, their preparation and therapeutic application thereof (2009-04-14),

13. 7230007 - Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom (2007-06-12),

14. 7098331 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2006-08-29),

15. 7078414 - Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them (2006-07-18),

Title: Arielle Genevois-Borella: Pioneering Innovator in Pharmaceuticals

Introduction: Arielle Genevois-Borella stands out as a trailblazing inventor whose relentless passion for innovation is matched only by her dedication to creating a positive impact on society. Hailing from Thiais, FR, her remarkable work continues to inspire future generations of innovators.

Latest Patents: With an impressive portfolio of 25 patents, Arielle Genevois-Borella's latest inventions include Arylvinylazacycloalkane compounds and methods of preparation and use thereof. These compounds play a pivotal role as ligands of various nAChRs, offering promising solutions for disorders within the central nervous system and gastrointestinal system. Additionally, her innovations extend to derivatives of 1-oxo-isoindoline-4-carboxamides and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamides, demonstrating her diverse expertise in pharmaceutical advancements.

Career Highlights: Arielle Genevois-Borella's groundbreaking contributions have been shaped by her tenure at renowned companies such as Rhone-Poulenc Rorer S.A. and Targacept, Inc. These experiences have not only honed her skills as an inventor but have also provided a platform for her transformative ideas to thrive in the pharmaceutical industry. Her innovative spirit and commitment to excellence have undoubtedly left a lasting impact on the field.

Collaborations: Throughout her career, Arielle Genevois-Borella has had the privilege of collaborating with esteemed professionals in the industry, including Serge Mignani and Jean-Claude Aloup. These collaborative efforts have not only enriched her inventions but have also fostered a culture of innovation and knowledge-sharing within the realm of pharmaceutical research.

Conclusion: In conclusion, Arielle Genevois-Borella's remarkable journey as an inventor underscores her unwavering commitment to pushing the boundaries of pharmaceutical innovation. Her pioneering spirit, coupled with her fervent dedication to creating solutions that benefit society, cements her position as a transformative figure in the world of inventions and patents. As her work continues to inspire and shape the landscape of innovation, Arielle Genevois-Borella stands as a beacon for aspiring inventors seeking to make a profound impact on the world.

This text is generated by artificial intelligence and may not be accurate.